These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glucosamine therapy for osteoarthritis: an update. Towheed TE; Anastassiades T J Rheumatol; 2007 Sep; 34(9):1787-90. PubMed ID: 17787046 [No Abstract] [Full Text] [Related]
6. [Clinical study of a new drug for arthrosis]. Vinel P; Anklewicz J; Bayourthe L Therapeutique; 1971 Dec; 47(10):839-43. PubMed ID: 4259610 [No Abstract] [Full Text] [Related]
7. [The influence of the pharmaceutical industry on treatment guidelines]. Kramers C; Wuis E; Schouwenberg B Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803 [No Abstract] [Full Text] [Related]
8. Hype about glucosamine. Adams ME Lancet; 1999 Jul; 354(9176):353-4. PubMed ID: 10437858 [No Abstract] [Full Text] [Related]
9. Guilt by association. Somberg J Am J Ther; 2007; 14(3):229-30. PubMed ID: 17515693 [No Abstract] [Full Text] [Related]
10. The pharma industry--redressing the balance. Panay N; Fenton A Climacteric; 2008 Oct; 11(5):353-4. PubMed ID: 18781478 [No Abstract] [Full Text] [Related]
12. Why are clinical trials of glucosamine no longer uniformly positive? McAlindon T Rheum Dis Clin North Am; 2003 Nov; 29(4):789-801. PubMed ID: 14603583 [TBL] [Abstract][Full Text] [Related]
13. [Physicians and drug industry--one more time]. Rørtveit G Tidsskr Nor Laegeforen; 2008 Feb; 128(5):553. PubMed ID: 18311195 [No Abstract] [Full Text] [Related]
14. Declaration of conflicts of interest in scientific publications. Möller HJ World J Biol Psychiatry; 2009; 10(1):2-5. PubMed ID: 19140091 [No Abstract] [Full Text] [Related]